Institute of Pathology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Style-Extracting Diffusion Models for Semi-supervised Histopathology Segmentation (2025) Öttl M, Wilm F, Steenpaß J, Qiu J, Rübner M, Hartmann A, Beckmann M, et al. Conference contribution, Original article Re-identification from histopathology images (2025) Ganz J, Ammeling J, Jabari S, Breininger K, Aubreville M Journal article Architectural crypt distortions in ulcerative colitis: Time for reappraisal (2024) Rubio CA, Lang-Schwarz C, Vieth M Journal article, Review article Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical evaluation and histopathological correlation (2024) Bayerl N, Adams LC, Cavallaro AJ, Bäuerle T, Schlicht M, Wullich B, Hartmann A, et al. Journal article Corrigendum to “Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations” [Eur J Cancer 207 (2024) 114158](S0959804924008141)(10.1016/j.ejca.2024.114158) (2024) Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, et al. Journal article, Erratum Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation (2024) Soleder S, Gengenbacher N, Mogler C, Eckstein M, Runge A, Kriegmair MC, Augustin HG Journal article DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification (2024) Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, Schleich K, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article